Merck Makes Deal to Develop Schizophrenia Drug
15688
Merck agreed to pay a Swiss company, Addex Pharmaceuticals, as much as $702 million to help develop a new schizophrenia drug.
738835
Merck & Co.  said on Thursday its $1.1 billion deal to buy Sirna Therapeutics Inc. cleared an antitrust hurdle and said the deal could close as early as the end of this month.
214430
With its stock plunging, drug giant Merck has adopted a plan that could give top executives big bonuses if the company is taken over.
200022
NEW YORK, Nov. 29 -- Drugmaker Merck & Co., under financial siege since pulling its top painkiller Vioxx off the market in September, said Monday it has adopted a plan that would guarantee large severance packages to 230 top executives if the company merges or is taken over.
331733
Researchers said on Monday they have pinpointed the reason some drugs used to treat mental illnesses like schizophrenia cause patients to gain a lot of weight, raising hope for developing drugs without this side effect.
103036
A trial of a new type of schizophrenia drug shows promise in patients.
758408
WASHINGTON -- The Food and Drug Administration on Wednesday approved a widely used adult psychiatric drug for the treatment of schizophrenia and bipolar disorder in children and adolescents.
531882
FRANKFURT/ZURICH  - Germany drugmaker Merck KGaA   MRCG.DE unveiled a surprise 16.6-billion-Swiss franc ($13.3   billion) deal on Thursday to buy Swiss biotech firm Serono,   creating a new force in European pharmaceuticals.
110719
German drugmaker Merck MRCG.DE on   Thursday agreed to buy a 64.5 percent stake in rival Serono   SEO.VX in a surprise deal valued over 10 billion Swiss francs   ($8.3 billion), creating a new force in European   pharmaceuticals.
147168
The approval of a new drug is a long-term opportunity.
581751
THE REGION Idera Pharmaceuticals Inc. of Cambridge signed a drug-development deal with Merck &amp; Co. in which the New Jersey drug giant will pay $20 million cash and buy $10 million in stock for the rights to use Idera's immune-boosting technology in potential Merck vaccines. If the vaccines succeed, the deal could be worth up to $425 million in additional ...
10738
A partnership deal has investors in the small specialty pharma excited.
296490
The small pharmaceutical firm signs another big deal.
480970
Swiss biotech company Addex Pharmaceuticals SA  said it could receive more than $700 million from Merck & Co Inc  for a licensing deal on its ADX63365 drug to treat schizophrenia, lifting its shares.
424285
A federal advisory panel has backed Eli Lilly & Companyâs proposed long-acting form of its schizophrenia drug Zyprexa.
155751
NEW YORK/WHITEHOUSE STATION, New Jersey  - Merck & Co.  expects to seek U.S. approval in 2007 for drugs to treat HIV, cholesterol and insomnia, and it aims to have another four products in late-stage trials by mid-year, the company said on Tuesday.
157645
Biotechnology company Rigel  Pharmaceuticals Inc. RIGL.O has entered into a collaboration  pact with drugmaker Merck & Co. Inc. MRK.N to find treatments  for cancer and potentially other diseases, Rigel said on  Monday.